M. E. Cooper
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes 3
- Renal Diseases and Glomerulopathies 2
-
- Natural Antidiabetic Agents Studies 2
- Hormonal Regulation and Hypertension 2
-
- Blood Pressure and Hypertension Studies 5
- Renin-Angiotensin System Studies 4
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research 2
- Pharmacology top 10%
-
- Vanadium and Halogenation Chemistry 1
M. E. Cooper
13 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Nephrology 771
- Endocrinology, Diabetes and Metabolism 842
- Cardiology and Cardiovascular Medicine 1.1k
- Clinical Biochemistry 202
- Pharmacology 166
Countries citing papers authored by M. E. Cooper
This map shows the geographic impact of M. E. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Cooper more than expected).
Fields of papers citing papers by M. E. Cooper
This network shows the impact of papers produced by M. E. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Cooper. The network helps show where M. E. Cooper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. E. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 16 | |
| 2 | 2006 | 67 | |
| 3 | 2005 | 32 | |
| 4 | 2004 | 66 | |
| 5 | 2002 | 416 | |
| 6 | 2001 | 213 | |
| 7 | Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) studybreakdown → | 2000 | 745 |
| 8 | 2000 | 89 | |
| 9 | 1999 | 53 | |
| 10 | 1998 | 184 | |
| 11 | 1997 | 4 | |
| 12 | 1992 | 45 | |
| 13 | 1988 | 42 |
About M. E. Cooper
M. E. Cooper is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Cardiology and Cardiovascular Medicine and Anesthesiology and Pain Medicine, having authored 13 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (5 papers), Renin-Angiotensin System Studies (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Natural Antidiabetic Agents Studies (2 papers), Advanced Glycation End Products research (2 papers), Renal Diseases and Glomerulopathies (2 papers), Hormonal Regulation and Hypertension (2 papers) and Vanadium and Halogenation Chemistry (1 paper). The work is most often cited by research in Nephrology (771 citations), Endocrinology, Diabetes and Metabolism (842 citations), Cardiology and Cardiovascular Medicine (1.1k citations), Clinical Biochemistry (202 citations) and Pharmacology (166 citations). M. E. Cooper has collaborated with scholars based in Australia, Denmark and United States. Frequent co-authors include B. M. Brenner, Dick de Zeeuw, C. E. Mogensen, Steen Neldam, I. Tikkanen, S Oren, R J Viskoper, R. W. E. Watts, Terri J. Allen and Geoffrey Boner. Their work appears in journals such as Diabetologia, Clinical Chemistry and Laboratory Medicine (CCLM), Diabetes, Current Eye Research and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.